. Author manuscript; available in PMC: 2015 Nov 12.

Published in final edited form as: Am J Cardiol. 2010 Mar 19;105(9):1348–1352. doi: 10.1016/j.amjcard.2009.12.054

Table 3. Adjusted associations between time-dependent statin use and mortality stratified by baseline D-dimer level^*.

D-Dimer (μg/ml)	All-Cause Mortality				Cardiovascular Mortality

	Participants	Deaths	HR (95% CI)	p Value	Participants	Deaths	HR (95% CI)	p Value
<0.65
Statin nonuser	163	33	1.0 (referent)	NA	163	9	1.0 (referent)	NA
Statin user	119	21	0.45 (0.17–1.18)	0.10	119	5	0.26 (0.04–1.64)	0.15
>0.65
Statin nonuser	167	48	1.0 (referent)	NA	167	19	1.0 (referent)	NA
Statin user	120	25	0.49 (0.25–0.95)	0.034	120	9	0.26 (0.09–0.79)	0.018

Adjusted for age, gender, race, ankle brachial index, body mass index, pack-years of cigarette smoking, stroke, myocardial infarction, angina, heart failure, diabetes mellitus, history of hypertension, pulmonary disease, cancer, total cholesterol, high-density lipoprotein cholesterol, blocks walked in past week, and WALCS I versus WALCS II cohort.

Table 3. Adjusted associations between time-dependent statin use and mortality stratified by baseline D-dimer level*.

Table 3. Adjusted associations between time-dependent statin use and mortality stratified by baseline D-dimer level^*.